INS and diabetic ketoacidosis: The novel coronavirus may affect insulin-producing pancreatic β cells (β-IPPs), being responsible for their apoptosis, decreased insulin levels, and increased insulin requirements in patients with COVID-19 leading to diabetic ketoacidosis and diabetes [62].